Ciba Vision Group Financial Problems Research Paper

PAGES
2
WORDS
660
Cite

Alcon must learn from such innovative stands, and incorporate these ideas into its own medical offerings in its surgical, pharmaceutical, and vision care products. By bringing the R&D components of all satellite organizations into one entity, it will be able to make use of some of the innovative thinking present at CIBA. However, it must be careful to ensure that this is genuinely a learning effort, and ensure that Alcon does not stifle the values that made CIBA so strong since its founding in the 1980s.

Problem #3: Mix insider insight with outside observation

Generating synergy also requires homogeneous 'tracking' tools to ensure that the different components of the newly merged entity are being judged by the same standards. Currently, management of the company is unified at its regional and national levels, although sales and marketing departments are segmented based upon the specific designation (CIBA or Alcon) of different departments (Chavers & Mota 2010). Some clear benefits can be derived from this structure, given that sales and...

...

But balancing the need to keep track of overall metrics may be challenging, unless management of all financial data is consolidated under Alcon, to ensure a consistent approach of the company towards costs even while preserving regional integrity of sales and marketing campaigns.

Sources Used in Documents:

References

Alcon products for eye care and health. (2011). Alcon Official Website. Retrieved May 27, 2011

at http://www.alcon.com/en/alcon-products/index.aspx

Chavers, Gabrielle & Melissa Mota. (2010). Alcon and Novartis complete merger and form new

Alcon division to accelerate global leadership in eye care. Retrieved May 27, 2011 at http://www.alcon.com/en/docs/AlconTradeRelease.pdf
http://www.cibavision.com/innovation/research-and-development.shtml


Cite this Document:

"Ciba Vision Group Financial Problems" (2011, May 27) Retrieved May 4, 2024, from
https://www.paperdue.com/essay/ciba-vision-group-financial-problems-45045

"Ciba Vision Group Financial Problems" 27 May 2011. Web.4 May. 2024. <
https://www.paperdue.com/essay/ciba-vision-group-financial-problems-45045>

"Ciba Vision Group Financial Problems", 27 May 2011, Accessed.4 May. 2024,
https://www.paperdue.com/essay/ciba-vision-group-financial-problems-45045

Related Documents
Market Driven Management
PAGES 75 WORDS 25695

Pharmaceutical industries have to operate in an environment that is highly competitive and subject to a wide variety of internal and external constraints. In recent times, there has been an increasing trend to reduce the cost of operation while competing with other companies that manufacture products that treat similar afflictions and ailments. The complexities in drug research and development and regulations have created an industry that is subject to intense

Japanese-American Biopharmaceutical Industry in the 21st Century Optimizing Ethical Drug Availability Between These Two Pharmaceutical Superpowers" The Japanese-American biopharmaceutical industry represents an ongoing international effort between the two top pharmaceutical markets in the world. These two economic powers provide consumers with a majority share of all pharmaceuticals produced in the world. However, a number of pharmaceutical products that are currently available to U.S. residents are unavailable to Japanese consumers. From a humanitarian perspective, this